A Randomized, Double-blind, Phase IIb Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine (FQ) With Artefenomel (OZ439) in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Artefenomel (Primary) ; Artefenomel/ferroquine (Primary) ; Ferroquine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- Acronyms FALCI
- Sponsors Sanofi
- 10 Jan 2018 Planned End Date changed from 2 Jul 2019 to 23 Jul 2019.
- 10 Jan 2018 Planned primary completion date changed from 2 Jul 2019 to 23 Jul 2019.
- 18 Dec 2017 Planned End Date changed from 1 Feb 2019 to 2 Jul 2019.